SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-24-034238
Filing Date
2024-11-08
Accepted
2024-11-08 17:14:02
Documents
21

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 pirs20241107_424b3.htm 424B3 8868340
2 d01.jpg GRAPHIC 37249
3 d02.jpg GRAPHIC 258191
4 d3.jpg GRAPHIC 88368
5 d05.jpg GRAPHIC 25010
6 d06.jpg GRAPHIC 284612
7 e01.jpg GRAPHIC 282422
8 e02.jpg GRAPHIC 228803
9 image02s4.jpg GRAPHIC 77994
10 image03s4.jpg GRAPHIC 75167
11 image05s4.jpg GRAPHIC 36568
12 image06s4.jpg GRAPHIC 56430
13 image08s4.jpg GRAPHIC 92671
14 image11s4.jpg GRAPHIC 257160
15 image12s4.jpg GRAPHIC 63745
16 image13s4.jpg GRAPHIC 37666
17 image15s4.jpg GRAPHIC 139938
18 image16s4.jpg GRAPHIC 39077
19 logom03.jpg GRAPHIC 11259
20 logom04.jpg GRAPHIC 14692
21 p02.jpg GRAPHIC 34607
  Complete submission text file 0001437749-24-034238.txt   11820517
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-281459 | Film No.: 241441780
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)